Meta Delays New Commercial Terms to November 20
Meta said it will delay implementation of updated commercial terms from October 30 to November 20 to address concerns from publishers and digital advertisers.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
7 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Commercial Metals Q4 2026 Earnings Call Transcript
Commercial Metals reported fiscal 2026 core EBITDA of approximately $1.4 billion, while fourth-quarter core EBITDA rose 35.1% year over year. Management outlined fiscal 2027 priorities including growth investments, portfolio reshaping and margin expansion.
Transcript: Vistra Q2 2026 Earnings Conference Call
Vistra (NYSE: VST ) reported second-quarter financial results on Friday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Vistra Corp reported strong
Full Transcript: Rockwell Automation Q3 2026 Earnings Call
Rockwell Automation (NYSE: ROK ) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Rockwell Automa
Red Rock Resources gives general business update on DRC JV and litigation
The company said receipt of the first DRC housing JV payment is now expected in early October, while a judgment in proceedings with VUP remains pending. It also said it is evaluating copper-cobalt mining areas in the DRC and is focused on licence renewal in Kenya.
AstraZeneca to invest $2 billion in Summit Therapeutics
The companies also agreed to a clinical trial collaboration to evaluate ivonescimab with sonesitatug vedotin in gastrointestinal cancers. Summit said AstraZeneca’s investment will be in convertible preferred shares.
Dr Reddy's Laboratories Q1 2027 Earnings Call Transcript
Dr Reddy's Laboratories (NYSE: RDY ) held its first-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Dr Reddy's Laboratories reported a 5.6%